Videos | Nuclear Imaging

Gary Dillehay, M.D., FACR, FACNM, SNMMI president, explains some of the trends in Nuclear Imaging at the Society of ...

Time June 24, 2013
Home
Technology

Carestream Health announced U.S. Food and Drug Administration (FDA) clearance for a new wireless digital radiography detector designed to offer high quality, low-dose X-ray exams for pediatric, orthopaedic and general radiology applications.

Time June 24, 2013
Home
News

A new first for Georgia was celebrated Thursday, May 2, as Emory Healthcare and the Winship Cancer Institute broke ground on the new Emory Proton Therapy Center. Brasfield & Gorrie, the general contractor on the more than $200 million dollar oncology center, was joined in the celebration by developer Advanced Particle Therapy and elected officials, including Atlanta Mayor Kasim Reed.

Time June 24, 2013
Home
News

Soccer players who ‘head’ the ball with high frequency demonstrate poorer performance on memory tests and have brain abnormalities similar to those found in traumatic brain injury patients, according to a study published online in the journal Radiology.

Time June 21, 2013
Home
Feature

The Idaho Health Data Exchange (IHDE) and St. Luke’s Health System (SLHS) have launched Image Exchange viewing capability by eHealthTechnologies.

Time June 20, 2013
Home
Feature

No matter where they have hidden, metastatic prostate cancer cells still express some of the same signaling as normal prostate cells; in some cases even more so, as with the PSMA enzyme. Harnessing this enzyme could mean the beginning of a new platform for prostate cancer detection, staging, treatment and post-treatment monitoring, say researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.

Time June 20, 2013
Home
Feature

A relatively new weapon in the fight against childhood brain cancer has emerged that improves upon standard magnetic resonance imaging (MRI) by providing information about tumor metabolism and extent of cancer in children diagnosed with glioma, a growth caused by the abnormal division of glial cells in the brain, said researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.

Time June 20, 2013
Home
News

Alzheimer’s disease has been linked in many studies to amyloid plaque buildup in the brain, but new research is finding a common thread between amyloid burden and lower energy levels, or metabolism, of neurons in certain areas of the brain associated with Alzheimer’s disease — even for people with no sign of cognitive decline. This is a new development in the understanding of Alzheimer’s pathology, say neuroscientists presenting the research at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.

Time June 19, 2013
Home
News

June 19, 2013 — Coronary artery disease (CAD) is one of the world’s most prevalent and silent killers. Positron emission tomography (PET), which images miniscule abnormalities in cellular metabolism, can tip off clinicians about cardiac disasters waiting to happen — including sudden death from a heart attack — better than standard angiography, researchers revealed at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.

Time June 19, 2013
Home
Technology

The Philips 24-inch and 27-inch clinical review displays ensure that medical images are shown consistently with high quality to achieve reliable interpretations. The displays with clinical D-image preset are factory calibrated to give digital imaging and communications in medicine (DICOM) part 14 compatible grayscale standard display performance. By using high quality LCD panels with LED technology, Philips offers consistent and reliable performance at an affordable price point.

Time June 19, 2013
Home
News

Magnetic resonance imaging (MRI) scans of children who have had chemotherapy can detect early changes in their hearts finds research in biomed Central's open access journal Journal of Cardiovascular Magnetic Resonance.

Time June 19, 2013
Home
News

Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain. One of the newest studies of a proposed vaccine shows mixed results for patients after molecular imaging revealed no desirable effect and potentially allowed even more nicotine accumulation in the brain in some cases due to variations in immune response, say neuroscientists at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.

Time June 19, 2013
Home
News

Using positron emission tomography (PET) imaging of the brain, researchers have identified a sweet spot that operates in a disorderly way when simple sugars are introduced to people with insulin resistance, a precursor to type 2 diabetes. For those who have the metabolic syndrome, a sugar drink resulted in a lower-than-normal release of the chemical dopamine in a major pleasure center of the brain. This chemical response may be indicative of a deficient reward system, which could potentially be setting the stage for insulin resistance. This research could revolutionize the medical community’s understanding of how food-reward signaling contributes to obesity, according to a study being presented at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.

Time June 19, 2013
Home
News

By targeting both bone cell activity and immune response and improving imaging data interpretation, doctors can better distinguish diabetic foot infection from another common foot condition that often requires an additional bone-marrow scan for definitive diagnosis, say researchers presenting a study at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.

Time June 19, 2013
Home
News

Accurate estimation of radiation absorbed dose in radioimmunotherapy (RIT) based on state-of-the-art 3-D imaging could lead to more personalized and effective treatments to improve non-Hodgkin lymphoma (NHL) patients’ chances of living longer without progression of their cancer, said researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.

Time June 17, 2013
Home
Case Study

Supercharge processing productivity. EVP Plus image processing accelerates the capture set-up process and increases output quality. It provides greater efficiency and supports enhanced patient diagnosis. Download white paper to learn more.

Time June 17, 2013
Home
Feature

When prostate cancer makes a comeback, it becomes increasingly important to have exceptional imaging available to find all possible regions where cancer has spread to other parts of the body, or metastasized, in order to plan the best possible treatment. A relatively new imaging system that simultaneously combines positron emission tomography and magnetic resonance (PET/MR) demonstrates a higher capacity for mapping recurrent prostate cancer than the already high standard of integrated PET and computed tomography (PET/CT), say researchers presenting a study at the Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting.

Time June 17, 2013
Home
News

One of the biggest hurdles of hybrid positron emission tomography and magnetic resonance (PET/MR) imaging is the prevalence of motion artifacts—blurring and ghostly visual anomalies caused by patient motion on the table during imaging. An MR technology has now been designed for PET/MR that employs tiny radiofrequency solenoids—metal coils integrated into hardware placed on the body—to track motion from those who do not or cannot stay put. Special software can then use the additional information provided by the coils to optimize the image, according to research being revealed at SNMMI’s 2013 Annual Meeting.

Time June 17, 2013
Home
Technology

Intelerad Medical Systems announced the formation of a new Clinical Decision Support (CDS) Group. The Toronto-based group is made up of developers who will focus on adding evidence-based decision support and data mining features to Intelerad’s solution portfolio.

Time June 17, 2013
Home
Feature

The Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting marks the unveiling of the successful application of a new preclinical hybrid molecular imaging system—single photon emission tomography and magnetic resonance (SPECT/MR)—which has exceptional molecular imaging capabilities in terms of potential preclinical and clinical applications, technological advancement at a lower cost, and reduction of patient exposure to ionizing radiation.

Time June 17, 2013
Home
Subscribe Now